QIAGEN Inc.
27220 Turnberry Lane
Suite 200
Valencia
California
91355
United States
Tel: 800-426-8157
Fax: 800-718-2056
Website: http://www.qiagen.com/
About QIAGEN Inc.
QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.
Further information about QIAGEN can be found at http://www.qiagen.com/.
114 articles about QIAGEN Inc.
-
QIAGEN Inc. Launches Novel Product Enabling Non-Invasive Prenatal Diagnostics and Cancer Detection
5/26/2009
-
QIAGEN Inc. Tests Clinically Verified for the Monitoring of Swine Flu
5/1/2009
-
QIAGEN Inc. Tests Clinically Verified for the Monitoring of Swine Flu
4/30/2009
-
QIAGEN Inc. Provides Solutions for Swine Flu Surveillance
4/28/2009
-
QIAGEN Inc. First Quarter 2009 Financial Results Call Set for May 5
4/28/2009
-
QIAGEN Inc. Virus Test Cuts Deaths From Cervical Cancer, Indian Researchers Report
4/2/2009
-
QIAGEN Inc. Welcomes 3,000th Employee in 20th year of U.S. Operations
12/16/2008
-
Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer QIAGEN Inc.'s Digene HPV Test Selected for World's First National HPV Screening Program
11/19/2008
-
QIAGEN Inc. and Chinese Academy of Sciences Form Collaboration for Development of New Molecular Food Safety Tests
9/25/2008
-
GENEART AG Extends Strategic Partnership with QIAGEN Inc. to Commercialize Synthetic Human Genes
9/4/2008
-
QIAGEN Inc. Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients
8/19/2008
-
QIAGEN Inc. (JOBS) Acquires Corbett Life Science for $66 Million
7/1/2008
-
QIAGEN Inc. Announces First Quarter 2008 Earnings Conference Call
5/6/2008
-
Webcast of QIAGEN N.V.'s First Quarter 2008 Financial Results Call Set for May 6
4/29/2008
-
QIAGEN Inc. Opens Asia Customer Service Center
2/22/2008
-
QIAGEN Gaithersburg Inc. and Ventana Medical Systems, Inc. Announce Settlement of Patent Dispute
12/20/2007
-
QIAGEN Inc. Reports Third Quarter 2007 Results Increases Full Year 2007 Guidance
11/6/2007
-
QIAGEN Inc. Invites You to Join Its Third Quarter 2007 Earnings Conference Call
10/30/2007
-
QIAGEN Inc. NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk
10/18/2007
-
QIAGEN Inc. Invites You to Join Its First Quarter 2007 Earnings Conference Call on the Web
5/2/2007